We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
From the Editorial Office.
- Authors
Rothrock, John F.
- Abstract
The author discusses on the Food and Drug Administration (FDA) issuing a public advisory warning of the potential danger of serotonin syndrome resulting from concomitant use of a triptan and an SSRI/SNRI in 2010 and a paper published in the journal by Evans and colleagues, responding to the FDA's cautionary proclamation. He states that articles in the issue include the letter from Dr. Fine and Dr. Bastings on the paper published and a rebuttal written by the authors of the original article.
- Subjects
SEROTONIN syndrome; SERIAL publications; UNITED States. Food &; Drug Administration; DISEASE risk factors
- Publication
Headache: The Journal of Head & Face Pain, 2012, Vol 52, Issue 7, p1069
- ISSN
0017-8748
- Publication type
Article
- DOI
10.1111/j.1526-4610.2012.02200.x